Mode
Text Size
Log in / Sign up

Feasibility of 30-day smartphone assessment in 177 adults with migraineSmartphones Track Migraine Brain Fog Better Than Doctor Visits

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note feasibility of 30-day smartphone assessment in 177 adults with migraine; safety and efficacy not reported.

This cohort study enrolled 177 adults meeting International Classification of Headache Disorders, 3rd edition, criteria for migraine. The setting involved remote enrollment with smartphone-based assessment. The intervention consisted of a 30-day smartphone-based assessment including once-daily ecological momentary assessments and mobile cognitive tasks. The comparator was not reported.

Regarding enrollment, 177 participants were included. The mean age was 38.8 years (SD 11.9), and 79.7% were female. Chronic migraine prevalence was 45.2% (80/177 participants). The study followed participants for 30 days.

Feasibility metrics showed 3688 daily assessments were completed, representing 70.8% of all possible study days. Participants completing at least 20 days accounted for 70.6% of the cohort. Completion rates across study days were above 60%. Baseline demographics and migraine characteristics were collected. MIDAS scores were 98.6 for chronic migraine, 38.7 for low-frequency episodic migraine, and 70.3 for high-frequency episodic migraine. Days with concentration difficulty were 16.0, 7.9, and 11.5, respectively. Days with functional interference were 18.5, 7.6, and 13.0, respectively.

Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. The study limitations include the absence of a comparator group and lack of reported adverse events. Funding or conflicts of interest were not reported. The practice relevance demonstrates the feasibility of high-frequency smartphone-based assessment of cognition and symptoms in migraine. Causality was not reported, and certainty regarding clinical outcomes is not established.

  • Daily phone checks track brain fog better than clinic visits.
  • Adults with frequent or chronic migraine headaches benefit most.
  • This is a research tool, not a medical treatment yet.

A new study shows daily phone checks capture migraine brain fog better than office visits.

Imagine trying to remember your keys during a severe migraine. You might feel foggy, tired, or completely unable to focus on simple tasks. Doctors often ask about this during a quick office visit.

But that moment might not show the full picture of your health. Your brain feels different on a bad day compared to a good one. Relying on memory alone misses the real struggle you face.

Many people feel frustrated when their symptoms do not match the test results. They know they struggle more than they can explain in ten minutes. This gap leaves patients feeling unheard by their care team.

Why measuring brain fog is hard

Cognitive symptoms are a major part of migraine burden for many. Many people struggle with memory and focus during attacks. Current tests happen only once in a clinic.

This misses how symptoms change day to day in real life. A single visit cannot capture the ups and downs of your week. It is like trying to understand a whole movie from one photo.

We used to rely on memory and single visits for data. Patients often forget how bad things felt weeks ago. But here’s the twist.

The surprising shift in tracking

New technology allows daily checks right from your home. This method captures data while you are living your life. It removes the guesswork from the medical record.

Think of it like checking the weather forecast. A single photo shows one moment in time. But a video shows the whole storm over days.

This study used a phone app to record daily thoughts. It captured real-life changes in thinking and pain levels. Participants did simple tasks to test their focus.

Researchers asked 177 adults to use a phone app for 30 days. Participants had migraine and completed daily tasks. They measured mood, stress, and how hard it was to work.

Most people stuck with the study for most of the month. Over 70 percent of daily checks were completed successfully. This proves that patients can handle this kind of monitoring.

People with chronic migraine had more trouble concentrating on tasks. They reported 16 days of difficulty per month. Those with less frequent migraines reported about 8 days.

What they found about daily life

The phone data matched the real-world struggle perfectly for everyone. Chronic migraine patients also had higher disability scores overall. This confirms that brain fog is a heavy burden.

This doesn’t mean this treatment is available yet.

Experts see this as a major step forward for research. It proves people can track data from home reliably. This helps scientists understand the migraine cycle better.

What experts say about the future

It does not offer a new drug or cure for pain. But it changes how we study the condition. You cannot download this app for medical care today.

It is designed for researchers to gather data safely. If you struggle with brain fog, talk to your doctor. They can use this info to improve your care plan.

Ask if your clinic uses similar tracking tools now. Your feedback matters more than ever before for care. The group was small and mostly female patients.

It only looked at one month of data in total. We do not know if this works for everyone. More studies are needed to confirm these results.

The limits of this research

Some people might find daily tracking too tiring to do. We need to learn who benefits most from it. Scientists will use this data to find patterns.

What Happens Next for This Research

Future trials might test new treatments using this method. Approval for medical use takes time and safety checks. Stay tuned for updates on how this changes care. Scientists are working hard to make this data useful for everyone.

Study Details

Study typeCohort
Sample sizen = 177
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Objective: To describe the design, feasibility, and baseline characteristics of the Migraine Impact on Neurocognitive Dynamics (MIND) study, a 30-day smartphone-based cohort for high-frequency assessment of cognition and symptoms in adults with migraine. Background: Cognitive symptoms are an important component of migraine burden, but they are difficult to measure using single-visit testing or retrospective questionnaires. Repeated smartphone-based assessment may better capture real-world variability in cognition and symptoms. Methods: Adults meeting International Classification of Headache Disorders, 3rd edition, criteria for migraine were enrolled remotely and completed 30 days of once-daily ecological momentary assessments and mobile cognitive tasks delivered through the Mobile Monitoring of Cognitive Change platform. Baseline measures assessed demographics, migraine characteristics, disability, mood, stress, and treatment patterns. Feasibility was evaluated using enrollment, completion, and retention metrics. Results: A total of 177 participants enrolled (mean age 38.8 (SD 11.9) years; 79.7% female), including 80/177 (45.2%) with chronic migraine. Across the 30-day protocol, 3688 daily assessments were completed, representing 70.8% of all possible study days, and 70.6% of participants completed at least 20 days of monitoring. Completion remained above 60% across study days. At baseline, chronic migraine was associated with greater burden than low-frequency and high-frequency episodic migraine, including higher MIDAS scores (98.6 vs. 38.7 and 70.3), more days with concentration difficulty (16.0 vs. 7.9 and 11.5), and more days with functional interference (18.5 vs. 7.6 and 13.0). Conclusions: The MIND study demonstrates the feasibility of high-frequency smartphone-based assessment of cognition and symptoms in migraine and provides a methodological foundation for future analyses of within-person cognitive and symptom dynamics across the migraine cycle.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.